1/192
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Hyperlipidemia increases the risk of
CHD, stroke
CHD accounts for
1/7 deaths
how many americans on meds for hyperlipidemia?
more than half
how often to check cholesterol?
every 4-6y
atherogenesis steps
- Injury
- Inflam
- Fibrous Cap
- MPs cause rupture
- HA, stroke
in atherosclerosis ______________ build up under foam cells
lipids and plaque
atherosclerosis causes angina and SoB because
poor oxygenation
what does ASCVD risk calculator find?
10-year risk for 40-75 yo
which racial group highest risk for ASCVD?
African american
what are the greatest RFs for ASCVD?
smoking, high BP, diabetes
anything above ___________ cholesterol is dangerous
>130
must space fasting lipid panels by how long?
4-6wk
TG effect on CVD
- TG little effect on CVD
- mostly affect pancreas
Friedewald Formula
LDL = TC - HDL - (TG/5)
Clinical Presentation of HLD
- asymp
- metabolic syndrome
- symptoms of none to death
- signs of ab pain, pancreatitis, periph neuro, angina
- Labs
metabolic syndrome
- 3/5 of:
- HTN, insulin resist, ab obesity, prothromotic, atherogenic dyslipidemia
labs for HLD
- C-reactive protein
- lipid panel
Primary Hyperlipidemia
- genetics
- HoFH or HeFHyperchol
secondary hyperlipidemia
- diet
- drugs
- disease
- disorder
- most are a mixture
drug causes of hyperlipid
- steroids
- antipsychotics
- b blocker
- cyclosporin
- (weight gain)
nondrug causes of hyperlipid
- diabetes
- HIV
- anorexia
- preg
- malabs
the cornerstone of HLD therapy
dietary modification
HLD diet
- low trans fat
- high healthy fat
- fruit veg
- whole grain
- fish
other HLD lifestyle mods
- physical activity
- weight loss
- smoking cessation
goals of dyslipidemia treatment
- Correct lab abnorm
- Dec long term CV risk (prim and sec, and prevent prog)
- Prevent pancreatitis, HyperTG
primary prevention
treatment before ASCVD event
secondary prevention
treatment after ASCVD event
HMGCRs derive from
fungi
which statin from penicillium
mevastatin
which statin from aspergillus
lovastatin
red yeast rice
- low lovastatin
- little effect
what part of statins causes myalgias
Mevalonic acid
statin MoA
- inhib HMGCR
- inc LDL-r
- inc LDL removal
statins effects
- dec LDL
- dec TG
- inc HDL
pleiotropic effect is found in
- statins
- dec inflam and stabilize plaques
- dec risk CVD
statins CI
- liver disease
- preg X
- nursing
statins therapeutic uses
- dec risk
- nonfatal MI
- revasc
- stroke
- CVD mortality
statins indication
- HeFH HoFHyperchol
- prim and sec ASCVD
update on statins and preg
- CI nursing
- limit in preg
- ok for HoFH, estab ASCVD, high risk
- risk/benefit analysis
% pts intolerant statins
10%
statin AEs
- 25% myopathy
- rhabdo
- high LFT
- cog effects
- inc blood sugar and HbA1C
N of 1 statin study
% myalgias in placebo and statin are the same
RFs for statin AE
- mult comorb
- statin intol
- DDI
- >75y
why is age a statin AE RF
dec CL leads to inc AUC
Managing Statin Intolerance
- Dec and Rechallenge
- Rotate Statins
- Minimal Dose
- longer interval and long acting agents
- Lipophilic versus hydrophilic
dechallenge and rechallenge
stopping statin after AE and restarting on same dose or start on new drug low dose
which statin take with evening meal?
lovastatin
which statin take at bedtime?
- fluvastatin IR
- simvastatin
monitoring in statin therapy
- baseline LFT and FLP
- LFT initially q4-12wk
- LFT q3-12mo
statin 3A4 interactions
Atorvastatin
Lovastatin
Simvastatin
statin 2C9 interactions
Fluvastatin
Pitavastatin
Rosuvastatin
statin 2C19 interactions
Rosuvastatin
statin no CYP interactions
Pravastatin
high intensity statins
Atorvastatin 40-80
Rosuvastatin 20-40
statin therapeutic uses
Prim and sec ASCVD event
Jupiter trial
Rosuvastatin for prim (5-point MACE)
WOSCOPS trial
Pravastatin for prim
SPARCL trial
Atorvastatin for sec stroke
statin benefit groups
- clinical ASCVD
- LDL >190
- 40-75y w diabetes LDL 70-189
- 40-75y risk >7.5% LDL 70-189
sec >75 statin
mod intensity
sec <75 statin
high intensity
prim >190 LDL statin
high intensity
diabetes and risk >7.5% and LDL 70-189 and 40-75y statin
high intensity
diabetes and risk <7.5% and LDL 70-189 and 40-75y statin
mod intensity
prim prevent and >7.5% risk and 40-75y statin
mod or high intensity
LDL goal <70 for
- prev ASCVD event
- or familial hyperchol FH
LDL goal <100 for
- diabetes
- or ASCVD RFs
LDL goal <130 for
everyone else
ezetimibe MoA
- Blocks sterol transporter
- sm int brush border
- block abs
ezetimibe effects
- dec LDL
- dec TG
- inc HDL
- minimal
ezetimibe DDI
- space 2hr BABR
- inc cyclosporine
ezetimibe AE
- few
- combo best tolerated is statin
ezetimibe monitoring
LFT
Ezetimibe indications
- HoFH
- Homo sitosterol
- Prim hyperlipid
- Sec ACS
IMPROVE-IT trial
- ezetimibe and simvastatin
- dec CV event in pts at LDL goal
- combo > mono
- but other trials show no benefit
BABR mechanism
Bind BA in int and exc feces
BABR effects
- dec LDL
- inc HDL
- slight inc TG
BABR AE
constipation, bloating, flatulence
BABR DDI
dec abs fat solub vitamin
which drug is 1st line in preg
BABR
when to take meds w BABR
1h before or 4h after BABR
do not start BABR if
- TG >300
- pancreatitis bcs inc TG
discontinue BABR if
TG >400
BABR powder
- not as well tolerated
- use if can't swallow pills
BABR drugs
- Cholestyramine powder
- Colestipol powder
- Colesevelam tab
BABR off label
- for SEs
- diarrhea
- diabetes
PCSK9i MoA
- mAb
- inhib destruction LDL-r
- inc LDL
PCSK9i effects
- 60% dec LDL
- dec TG
PCSK9i trial
slight dec CV death after ACS (sec)
PCSK9i AE
- nasopharyngitis
- allergic rxn
- injection rxn
- some liver
PCSK9i indication
- HoFM mono
- Prim hyperlipid
- Sec Prevent CV event w estab CVD
PCSK9i drugs
- Alirocumab (Praluent)
- Evolocumab (Repatha)
which is the only drug for 1st line HoFH?
PCSK9i
which product is available SC monthly?
Evolocumab (Repatha) PUSHTRONEX
downside of PCSK9i
expensive
Inclisiran MoA
- small interfering RNA (siRNA)
- dec prod PCSK9 by inhib mRNA
which drug is billed through medical insurance?
- Inclisiran
- SC in office
- good for adherence
Inclisiran effect
dec LDL 50% combo high intensity statin
Inclisiran indications
adj in HeFH or ASCVD
ORION-4 trial
- Inclisiran
- effect on ASCVD